US top court to hear case on gene patents
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Genetics
Apr 13, 2013 |
5 / 5 (2) |
0
Are human genes patentable?
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics
Apr 11, 2013 |
4.3 / 5 (6) |
16
|
Misuse of drug patenting could cost the health system billions
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications
Apr 10, 2013 |
5 / 5 (1) |
0
|
India's top court to deliver Novartis judgment
India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies ...
Medications
Mar 31, 2013 |
not rated yet |
0
Indian court to rule on generic drug industry
(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will ...
Medications
Jan 04, 2013 |
not rated yet |
0
India generics giant wins cancer drug patent case
Indian generics giant Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over the Mumbai firm's version of a lung-cancer drug.
Medications
Sep 08, 2012 |
5 / 5 (4) |
2
US Congress sends Obama major patent overhaul
The US Senate Thursday passed legislation to drag the web of US patent laws into the Internet age and spur high-tech innovation, sending the measure to President Barack Obama to sign into law.
Health
Sep 09, 2011 |
not rated yet |
1
India patent case threatens cheap drug supply: MSF
Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.
Medications
Sep 05, 2011 |
5 / 5 (4) |
1
